|
Real-time
Euronext Paris
11:08:04 30/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 1.760 EUR | -3.30% |
|
+3.32% | -47.49% |
| 10-29 | DBV Technologies sharply lower as cash runway and dilutive financing raise concerns |  |
| 10-29 | DBV Technologies S.A., Q3 2026 Earnings Call, Oct 28, 2026 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| DBV TECHNOLOGIES | Specialty & Advanced Pharmaceuticals | -3.30% | +3.32% | -47.49% | -29.70% | -69.81% | 601M |  |  | |
- Stock Market
- Stocks
- DBV Stock
- Charts DBV Technologies
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
